Evidence map›Paper›PMID 40703149›Full record

ArticleCurrent research in food science2025

Bread crust extract is a novel activator of aryl hydrocarbon receptor and modulator of NRF2 and NFκB in HepG2 and HCT 116 cells.

Anne Grosskopf, Merve Kuru-Schors, Saskia Schmidt, Jennifer Dienel, Annika Höhn, Jana Raupbach, Kristin Wächter, Conny Köhler, Tilman Grune, Gábor Szabó and 1 more

Abstract read
In one paragraph

Article in Current research in food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anne GrosskopfClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Merve Kuru-SchorsClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Saskia SchmidtClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Jennifer DienelClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Annika HöhnDepartment of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
Jana RaupbachDepartment of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
Kristin WächterClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Conny KöhlerClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Tilman GruneDepartment of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
Gábor SzabóClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Andreas SimmClinic for Cardiac Surgery, University Medicine Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Maillard reaction describes the non-enzymatic formation of advanced glycation end products (AGEs), e.g., during thermal food processing. Studies on the mode of action and health implications of food-derived AGEs are often contradictory and lack information on active components. We use bread crust extract (BCE) as a model for an AGE-rich diet. Despite the identified AGEs and known activated signaling pathways, it is still unclear which receptors can exert the various effects described for BCE. This study investigates whether BCE can induce the aryl hydrocarbon receptor (AHR), the downstream NRF2 and NFκB signaling pathways and if this activation can be attributed to individual, free AGEs or AHR-agonists present in BCE. HepG2 reporter cell results showed activation of AHR and NRF2 but not NFκB by BCE. However, the tested free AGEs did not show an activation. Known AHR-(pro-)agonists kynurenine (Kyn) and benzo[a]pyrene (BaP), both present in BCE, activated the reporter to a similar extent as BCE with distinct differences in target gene induction of CYP1A1, interleukin-8, heme oxygenase 1 and Manganese-superoxide dismutase. Furthermore, CYP1A1 ethoxyresorufin-O-deethylase enzymatic activity was also induced and could be modulated by AHR and NRF2-inhibition. In contrast, in HCT 116 pTRAF reporter cells, BCE activated AHR, NFκB and NRF2 and induced CYP1A1. We conclude that BCE contains potent AHR activators that influence cellular signaling activities. AHR most likely concerts cell line dependent NRF2 and NFκB-activation. The BCE effects are probably attributable to an interplay of AHR-agonists and AGEs.

Indexed as

Advanced glycation end productsAryl hydrocarbon receptorBread crust extractMaillard reactionNFκBNRF2

Identifiers

PMID40703149
PMCPMC12284547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.